2018
DOI: 10.2139/ssrn.3289797
|View full text |Cite
|
Sign up to set email alerts
|

Interim PET/CT Predicts Response in Pediatric Lymphoma Patients - Report of an IAEA Multicenter Prospective Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“… F18‐FDG PET is essential after an indicated number of cycles of chemotherapy. Early PET response in HL suggests improved prognosis 3,39 . CT or MRI may be needed if a change in size of masses is required (e.g., as part of a clinical trial). F18‐FDG PET is indicated at end of therapy unless interval PET is negative, in which case it may not need to be repeated.…”
Section: Imaging At Interim and End‐of‐therapy Follow‐upmentioning
confidence: 99%
See 1 more Smart Citation
“… F18‐FDG PET is essential after an indicated number of cycles of chemotherapy. Early PET response in HL suggests improved prognosis 3,39 . CT or MRI may be needed if a change in size of masses is required (e.g., as part of a clinical trial). F18‐FDG PET is indicated at end of therapy unless interval PET is negative, in which case it may not need to be repeated.…”
Section: Imaging At Interim and End‐of‐therapy Follow‐upmentioning
confidence: 99%
“…F18‐FDG PET is essential after an indicated number of cycles of chemotherapy. Early PET response in HL suggests improved prognosis 3,39 . CT or MRI may be needed if a change in size of masses is required (e.g., as part of a clinical trial).…”
Section: Imaging At Interim and End‐of‐therapy Follow‐upmentioning
confidence: 99%